Peer Reviewed: Numerical Simulation of Tablet Coating - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Peer Reviewed: Numerical Simulation of Tablet Coating
The authors investigate the tablet-coating process using a combination of different simulation techniques.

Pharmaceutical Technology
Volume 36, Issue 9, pp. 52-55


Advanced numerical-simulation techniques can aid in the development and optimization of pharmaceutical tablet-coating processes. Investigating mixing performance and the resulting residence time distribution of different coating apparatus can be used to increase intra-tablet coating homogeneity. Numerical simulations of the interplay of drying air, spray, and tablet bed were used to examine both local and global coating performance. Computational results showed how the process parameters influence the film quality and coating uniformity. A usual rule-of-thumb is to place the nozzle at about one-third of the tablet bed, measured along the bed surface starting from the top. The study of different spray-nozzle setups showed that in terms of spray loss, following this rule indeed gave the best results. However, aiming the nozzle slightly away from the air inlet could reduce the amount of spray loss. Finally, inter-tablet coating variability was quantified by using the DEM method to determine the effects of tablet flow inside the coater in terms of residence time under the spray.

In addition to helping achieve a mechanistic understanding of the coating process, the computational data can be collected into in-silico design spaces, in which the correlation between critical process parameters and critical quality attributes provide an improved understanding of the design, optimization, and operation of industrial coating devices.

Gregor Toschkoff, Daniele Suzzi, PhD, and Siegfried Adam, PhD, are researchers at the Research Center for Pharmaceutical Engineering (RCPE) in Graz, Austria. Johannes Khinast*, PhD, is director of RCPE and head of the Institute for Process and Particle Engineering, Graz University of Technology, Inffeldgasse 21/a/II 8010 Graz, Austria, tel. +43 316 873 7978,

*To whom all correspondence should be addressed.

Submitted: Apr. 15, 2011; Accepted: Jan. 16, 2012.


1. A. Kalbag and C. Wassgren, Chem. Eng. Sci. 64 (11), 2705–2717 (2009).

2. D. Suzzi, S. Radl, and J.G. Khinast, Chem. Eng. Sci. 65 (21), 5699–5715 (2010).

3. B. Freireich and C. Wassgren, Chem. Eng. Sci. 65 (3), 1117–1124 (2010).

4. S. Tobiska and P. Kleinebudde, Intl. J. Pharmaceutics 224 (1–2), 141–149 (2001).

5. L. Ho et al., J. Control. Rel., 119 (3), 253–261 (2007).

6. W.R. Ketterhagen, M.T. am Ende, and B.C. Hancock, J. Pharm. Sci. 98 (2), 442–470 (2009).

7. A. Alexander, T. Shinbrot, and F.J. Muzzio, Powd. Tech. 126 (2), 174–190 (2002).

8. G. Toschkoff et al., AIChE J. 58 (2), 399–411 (2012).

9. D. Suzzi et al., Chem. Eng. Sci. 69 (1), 107–121 (2012).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here